BioSpace News Archive

BION has reimagined the world of dialysis technical operations, providing efficient, cost effective strategies to maintain dialysis equipment, nationwide.

Fusion Genomics announced today that the company has been selected to conduct a first-of-its-kind pilot study using its sequencing-based infectious disease ONETest platform to detect SARS-CoV-2 and its variants.

Osteal Therapeutics, Inc. (“Osteal”), a clinical-stage biopharmaceutical company developing a new category of combination therapies for musculoskeletal infections, announced today the completion of an oversubscribed $30 million Series B equity financing.

CoreLink, LLC, a leading designer and manufacturer of spinal implant systems, announced 510 clearance from the U.S. Food and Drug Administration for the addition of Fusation™ anchors to the F3D-C2 Cervical Stand-alone Fusion System.

DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments.

Mustang Bio, Inc. today announced completion of a $75 million long-term debt facility with Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to both venture and non-venture backed companies.

Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke will present a corporate overview in-person at the 34th Annual Roth Conference.

AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting dry eye disease (DED), today announced that it has successfully developed a rapid quantitative tear test for MMP-9, an inflammatory biomarker for Dry Eye Disease.

Akerna (Nasdaq: KERN), a leading enterprise software company and developer of the most comprehensive technology infrastructure, ecosystem, and compliance engine powering the global cannabis industry, today announces that management will report its financial results for the fourth quarter and full year ended December 31, 2021.

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, will participate in the KeyBanc Life Sciences and Medtech Investor Forum being held virtually on Tuesday, March 22, 2022.